摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苯丙氨酰-苯丙氨酸甲酯盐酸盐 | 38017-65-1

中文名称
苯丙氨酰-苯丙氨酸甲酯盐酸盐
中文别名
——
英文名称
H-Phe-Phe-OMe*HCl
英文别名
L-phenylalanyl-L-phenylalanine methyl ester hydrochloride;HCl*H-Phe-Phe-OMe;H-Phe-phe-ome hcl;methyl (2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoate;hydrochloride
苯丙氨酰-苯丙氨酸甲酯盐酸盐化学式
CAS
38017-65-1
化学式
C19H22N2O3*ClH
mdl
——
分子量
362.856
InChiKey
CVAWZIWMXQMICB-QJHJCNPRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    195 °C (decomp)

计算性质

  • 辛醇/水分配系数(LogP):
    1.88
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    81.4
  • 氢给体数:
    3
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2924299090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:c2976f155152f47c36d676bf0315b17c
查看

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and biological activity of peptide hydroxamate inhibitors of degradation of substance P analogues
    摘要:
    A series of hydroxamic acid derivatives of peptides related to fragments of substance P (SP) were synthesized. Methyl, ethyl or N-hydroxy-succinimide ester precursors of the desired peptides were prepared by using classical peptide synthesis methodology and these were reacted with excess hydroxylamine in either ethanol or NN-dimethylformamide. The products were characterized by chromatographic methods, amino acid analysis and fast atom bombardment mass spectrometry. The inhibition of the degradation of the radiolabelled substrate desamino-[3-I-125-tyroSyl5]SP(5-11) ([(I-125)BH5]SP(5-11)) by these compounds in rat hypothalamus preparations was determined. The most potent inhibitors found were Boc-Phe-Phe-Phe-NHOH (12d, IC50 = 4-mu-M), Boc-Phe-Phe-Trp-NHOH (9, IC50 = 5-mu-M) and desamino-Tyr-Phe-Phe-Gly-NHOH (22, IC50 = 1.8-mu-M). A model describing the interaction of these compounds with the active site is proposed.
    DOI:
    10.1016/0223-5234(92)90001-h
  • 作为产物:
    参考文献:
    名称:
    4-Ethoxy-1,1,1-trifluoro-3-buten-2-one as a New Protecting Reagent in Peptide Synthesis
    摘要:
    提出4,4,4-三氟-3-氧代-1-丁烯基作为在肽合成中保护氨基酸N-H末端的合适保护基团。氨基酸与4-乙氧基-1,1,1-三氟-3-丁烯-2-酮反应生成N-保护的氨基酸,该保护基团可以通过酸性水解去除。使用N-4,4,4-三氟-3-氧代-1-丁烯基保护的氨基酸形成肽键时不会发生消旋化。
    DOI:
    10.1055/s-1991-26420
点击查看最新优质反应信息

文献信息

  • Building Nanowires from Micelles: Hierarchical Self-Assembly of Alternating Amphiphilic Glycopolypeptide Brushes with Pendants of High-Mannose Glycodendron and Oligophenylalanine
    作者:Yijiang Liu、Yufei Zhang、Zheyu Wang、Jue Wang、Kongchang Wei、Guosong Chen、Ming Jiang
    DOI:10.1021/jacs.6b05044
    日期:2016.9.28
    our great attention. TEM studies demonstrated that it is formed via a hierarchical self-assembly, i.e., a series of successive processes, including micellization, micelles alignment forming nanofilament, branching of the nanofilaments by micelles, and finally nanowire formation. As far as we know, such hierarchical self-assembly process with high complexity has not been observed in literature for glycopolypeptides
    模仿自然界中多样的糖缀合物结构一直是科学家的梦想。目前,肽和糖的天然缀合物的分层自组装结构无法通过线性糖多肽与单糖作为附件轻松实现。在这项工作中,通过使用一系列精心设计的交替两亲性糖多肽刷(AAGBs)与糖树突和短肽的悬垂物,实现了各种自组装形态,包括纳米线、纳米带和复合胶束,主要取决于数量比。氨基酸种类 (S/F) 的糖单位。在这些形态中,纳米线引起了我们的极大关注。TEM 研究表明,它是通过分层自组装形成的,即一系列连续过程,包括胶束化、胶束排列形成纳米丝,纳米丝通过胶束分支,最后形成纳米线。据我们所知,这种高度复杂的分层自组装过程在糖多肽甚至多肽的文献中都没有观察到,这将加深我们对天然糖缀合物自组装机制的理解,扩展仿生材料库。
  • Intramolecular Ligation of Carbonyl Oxygen to Central Zinc in Synthetic Oligopeptide-Linked Zinc-Porphyrins
    作者:Hitoshi Tamiaki、Ayumu Kiyomori、Kazuhiro Maruyama
    DOI:10.1246/bcsj.67.2478
    日期:1994.9
    Oligopeptide-linked zinc-porphyrins were prepared (oligopeptide = –Phem–Alan–OMe and porphyrin = 5,15-diaryl-2,3,7,8,12,13,17,18-octaethylporphyrin). 1H NMR, IR, visible, and CD spectra of the synthetic molecule in a chlorinated methane (CDCl3 or CH2Cl2) showed that the carbonyl oxygen of the N-terminal amino acid of the linked peptide should ligate the central zinc metal in the molecule as the axial ligand to form a pentacoordinated zinc-porphyrin. The coordination of the zinc with the peptide framework changed the optical and electrical properties, indicating that such ligation might control the reactivity in biological metallotetrapyrrole–protein systems as well as the coordination to the peptide residue.
    通过寡肽连接的锌卟啉被制备出来(寡肽=–Phem–Alan–OMe,卟啉=5,15-二芳基-2,3,7,8,12,13,17,18-八乙基卟啉)。合成分子在氯化甲烷(CDCl3或CH2Cl2)中的1H NMR、IR、可见光和CD光谱显示,连接肽的N-末端氨基酸的羰基氧应该作为轴向配体配位到分子中的中心锌金属,形成五配位的锌卟啉。锌与肽骨架的配位改变了光学和电学性质,表明这种配位可能在生物金属四吡咯蛋白系统以及肽残基的配位中控制反应性。
  • Urea-containing peptide boronic acids as potent proteasome inhibitors
    作者:Li-Qiang Han、Xia Yuan、Xing-Yu Wu、Ri-Dong Li、Bo Xu、Qing Cheng、Zhen-Ming Liu、Tian-Yan Zhou、Hao-Yun An、Xin Wang、Tie-Ming Cheng、Ze-Mei Ge、Jing-Rong Cui、Run-Tao Li
    DOI:10.1016/j.ejmech.2016.10.023
    日期:2017.1
    A novel class of urea-containing peptide boronic acids as proteasome inhibitors was designed by introducing a urea scaffold to replace an amido bond. Compounds were synthesized and their antitumor activities were evaluated. After two rounds of optimizations, the compound I-14 was found to be a potent proteasome inhibitor. Compared with Bortezomib, I-14 showed higher potency against the chymotrypsin-like
    通过引入尿素支架取代酰胺键,设计了一类新型的含尿素的肽硼酸作为蛋白酶体抑制剂。合成化合物并评估其抗肿瘤活性。经过两轮优化后,发现化合物I-14是有效的蛋白酶体抑制剂。与Bortezomib相比,I-14对人20S蛋白酶体的胰凝乳蛋白酶样活性具有更高的效力(IC 50  <1 pM),对四种不同癌细胞系具有相似的效力(IC 50  <10 nM),并且具有更好的药代动力学特征。此外,I-14在Bel7404小鼠异种移植模型中显着抑制了肿瘤的生长。I-14对蛋白酶体的优异抑制作用 通过对接和分子动力学研究进行了合理化。
  • Structural studies of β-turn-containing peptide catalysts for atroposelective quinazolinone bromination
    作者:A. J. Metrano、N. C. Abascal、B. Q. Mercado、E. K. Paulson、S. J. Miller
    DOI:10.1039/c6cc01428c
    日期:——

    X-Ray crystallography and NMR spectroscopy were used to investigate the effect of primary structure on both secondary structure and enantioselectivity in peptide-based catalysts for an atroposelective bromination reaction.

    X射线晶体学和核磁共振光谱学被用来研究肽基催化剂在对映选择性溴化反应中的一级结构对二级结构和对映选择性的影响。
  • Tritiated peptides. Part 11. Synthesis of [4-3H-Phe6]-, [4-3H-Phe11]-, and [4-3H-Phe6,11]-somatostatin and the metabolite [des-Ala1]-somatostatin
    作者:Mark C. Allen、Derek E. Brundish、John R. Martin、Roy Wade
    DOI:10.1039/p19810002040
    日期:——
    ion-exchange and high-pressure liquid chromatography, and by enzymic digestion of the products modified by reduction and aminoethylation. The synthesis of the metabolite [des-Ala1]-somatostatin is described. The syntheses of [Phe(I)6]-, [Phe(I)11]- and [Phe(I)6,11]-somatostatin are described.
    合成方法描述了生长抑素+在位置6和11的苯丙氨酸残基中分别用tri标记,在残基6和11处分别用by标记,分别通过完全保护的还原性碘化反应使比放射性活度分别为15.5、13.8和14.1 Cim mol –1。前体。半胱氨酸残基受S-三苯甲基保护,二硫键由碘化oxidation化的受保护前体形成。通过酸性水解,离子交换和高压液相色谱,以及通过酶消化经还原和氨乙基化改性的产物,评估产物的纯度。描述了代谢物[des-Ala 1 ]-生长抑素的合成。[Phe(描述了I)6 ]-,[Phe(I)11 ]-和[Phe(I)6,11 ]-生长抑素。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物